PreprintCited by 3Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Early neuronal reprogramming and cell cycle reentry shape Alzheimer’s disease progression

Open access
Meir, Roi, Schwartz, Gali, Adam, Miriam, Lapidot, Adi Avni, Cain, Anael, Green, Gilad Sahar, Menon, Vilas, Bennett, David A. +2 more·2025·bioRxiv (Cold Spring Harbor Laboratory)

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by hallmark pathologies, synaptic dysfunction, neuronal loss, gliosis and cognitive decline-dementia. Recent large-scale cell atlases of human AD brains exposed vulnerability of specific neuronal subtypes and highlighted early, coordinated glial responses, suggesting glial involvement in disease progression. However, the timing and nature of neuronal changes, differences between neuronal subtypes, and their coordination with glia remain unclear. Here, we used non-negative matrix factorization to identify co-expression gene programs in single-nucleus RNA profiles from the prefrontal cortex of 437 samples from donors whose clinical symptoms ranged between no cognitive impairment and AD dementia. This approach identified early coordinated transcriptional changes across all neuronal subtypes, preceding clinical symptoms of cognitive decline, and validated in independent snRNA-seq, proteomics, and ELISA datasets. We found neurons in AD undergo rapid modulation of synaptic genes, accompanied by convergence of neurons into two distinct programs: An oxidative stress and apoptosis program abundant in vulnerable neuronal subtypes, and a DNA damage and cell-cycle reentry program associated with resilient subtypes. Moreover, neuronal reprogramming was closely tied to glial responses, and diverged between AD to non-AD brain aging, suggesting neuro-glial coordinated reprogramming shapes the AD cascade and influences disease outcomes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2025.06.04.653670

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A prior study reported a 3- to 4-fold increase in the number of neurons expressing cell cycle reentry programs in advanced AD patients compared to healthy individuals.

    “Additionally, a prior study reported a 3‐ to 4‐fold increase in the number of neurons expressing cell cycle reentry programs in advanced AD patients compared to healthy individuals. 69”

    From Unique transcriptomic alterations in 5XFAD;PS19 mouse model identify glial lipid dysregulation and coordinated microglial–oligodendrocyte responses (2026) · cites this paper as [69]

    The section ‘Neurons converge to distinct programs of stress/apoptosis or cell-cycle reentry’ reports a 3- to 4-fold increase in advanced AD compared with healthy individuals. It specifies that the increase occurred in inhibitory and deep-layer (L4–6) excitatory neurons, but not L2–3 neurons; the citing sentence omits that limitation. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 53 · Cited by 3

Research works printed but not linked: 15

  1. Green, G. S. et al. Cellular communities reveal trajectories of brain ageing and Alzheimer's disease. Nature 1-12 (2024) doi:10.1038/s41586-024-07871-6. · DOI · Paper page
  2. Carbonetto, P., Sarkar, A., Wang, Z. & Stephens, M. Non-negative matrix factorization algorithms greatly improve topic model fits. Preprint at https://doi.org/10.48550/arXiv.2105.13440 (2022). · DOI
  3. Bonda, D. J. et al. Evidence for the progression through S-phase in the ectopic cell cycle re- entry of neurons in Alzheimer disease. Aging 1, 382 (2009).
  4. Barrio-Alonso, E., Hernández-Vivanco, A., Walton, C. C., Perea, G. & Frade, J. M. Cell cycle reentry triggers hyperploidization and synaptic dysfunction followed by delayed cell death in differentiated cortical neurons. Sci. Rep. 8, 14316 (2018).
  5. Marshe, V. S. et al. A factor-based analysis of individual human microglia uncovers regulators of an Alzheimer-related transcriptional signature. BioRxiv Prepr. Serv. Biol. 2025.03.27.641500 (2025) doi:10.1101/2025.03.27.641500. · DOI
  6. Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Neuropathological Alterations in Alzheimer Disease. Cold Spring Harb. Perspect. Med. 1, a006189 (2011).
  7. Comandante-Lou, N. et al. PLXNB1 and other signaling drives a pathologic astrocyte state contributing to cognitive decline in Alzheimer's Disease. bioRxiv 2025.02.24.639868 (2025) doi:10.1101/2025.02.24.639868. · DOI
  8. Pelucchi, S., Gardoni, F., Di Luca, M. & Marcello, E. Synaptic dysfunction in early phases of Alzheimer's Disease. in Handbook of Clinical Neurology vol. 184 417-438 (Elsevier, 2022).
  9. Grodstein, F., Wang, T., Leurgans, S. E., Wilson, R. S. & Bennett, D. A. Modifiable psychosocial risk factors and delayed onset of dementia in older populations: analysis of two prospective US cohorts. (2022) doi:10.1136/bmjopen-2021-059317. · DOI
  10. Carbonetto, P. et al. GoM DE: interpreting structure in sequence count data with differential expression analysis allowing for grades of membership. Genome Biol. 24, 236 (2023).
  11. Wu, T. et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The Innovation 2, 100141 (2021).
  12. Virshup, I., Rybakov, S., Theis, F. J., Angerer, P. & Wolf, F. A. anndata: Access and store annotated data matrices. J. Open Source Softw. 9, 4371 (2024).
  13. Traag, V. A., Waltman, L. & van Eck, N. J. From Louvain to Leiden: guaranteeing well- connected communities. Sci. Rep. 9, 5233 (2019).
  14. Traag, V. A. & Bruggeman, J. Community detection in networks with positive and negative links. Phys. Rev. E 80, 036115 (2009).
  15. Reichardt, J. & Bornholdt, S. Statistical mechanics of community detection. Phys. Rev. E 74, 016110 (2006).

Authors
Meir, R., Schwartz, G., Adam, M., Lapidot, A. A., Cain, A., Green, G. S., Menon, V., Bennett, D. A., De Jager, P. L., & Habib, N.
Affiliations
  • Hebrew University of Jerusalem (IL)
  • Columbia University Irving Medical Center (US)
  • Rush University Medical Center (US)
  • Center for Translational & Computational Neuroimmunology, Department of Neurology and Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University Irving Medical Center, New York, New York, USA
Corresponding author
Habib, Naomi
Venue
bioRxiv (Cold Spring Harbor Laboratory)
Publisher
openRxiv
Published
2025-06-06
OpenAlex
W4411081439
Cited by
3
References
53
Citations by year
2026: 3
Type
posted content
Language
en
Open access
Locations
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
Funders
  • Rush University
  • Israel Science Foundation
  • National Institutes of Health (AG015819)
  • National Institute on Aging (R01AG017917, U01AG046152, R01AG015819, P30AG010161, U01AG061356, RF1AG057473, U01AG072572, P30AG072975)
  • H2020 European Research Council (853409)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, neuronal reprogramming, cell cycle re-entry, neuronal cell types, prefrontal cortex, single-nucleus RNA sequencing, oxidative stress, apoptosis, DNA damage, brain aging, synaptic dysfunction, disease progression, cognitive decline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review